<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04504682</url>
  </required_header>
  <id_info>
    <org_study_id>IRB19-1600</org_study_id>
    <nct_id>NCT04504682</nct_id>
  </id_info>
  <brief_title>Ambulation With Labor Epidural in Obese Women</brief_title>
  <official_title>Neuraxial Analgesia With and Without Ambulation in Laboring Nulliparous Obese Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if ambulation with a labor epidural in place is&#xD;
      associated with decreased rate of cesarean delivery in obese patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese women are known to have increased risk of cesarean delivery and prolonged labors. Low&#xD;
      concentration epidural analgesia can achieve pain relief and allow for ambulation. Prior&#xD;
      investigations have not shown a benefit in cesarean delivery between those who ambulate with&#xD;
      an epidural and those who do not. These studies were conducted in women with normal weights.&#xD;
      It is unknown if ambulation with a labor epidural is beneficial in decreasing cesarean&#xD;
      delivery among obese women.&#xD;
&#xD;
      Obese women at term with a singleton pregnancy will be enrolled in this study. Patients will&#xD;
      receive their epidural analgesia when they desire per standard protocol at our institution.&#xD;
      Following epidural placement, a Modified Bromage Score and straight leg test will be&#xD;
      performed. If the patient passes the straight leg test and has a modified Bromage score &gt; 6,&#xD;
      the patient will be randomized to ambulation or no ambulation. Those in the no ambulation&#xD;
      group will have standard of care. Those in the ambulation group will wear a pedometer and a&#xD;
      mobile fetal monitoring device. They will be encouraged to ambulate for 20 minutes per hour&#xD;
      with another adult alongside them. Obstetric care will be standard of care.&#xD;
&#xD;
      On postpartum day one, the patient will be administered a Labor Agentry Scale. Chart review&#xD;
      will then be conducted to review maternal and neonatal outcomes.&#xD;
&#xD;
      The first ten patients will be part of a pilot study, all with intervention to determine&#xD;
      feasibility of monitoring and ambulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The person completing analysis will be blinded to the treatment group.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Cesarean Delivery Rate</measure>
    <time_frame>At time of delivery</time_frame>
    <description>Percent of cesarean delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Labor Duration</measure>
    <time_frame>From labor onset to time of delivery</time_frame>
    <description>Duration (hrs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Stage Duration</measure>
    <time_frame>From onset of labor until complete dilation</time_frame>
    <description>Duration (hrs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Second Stage Duration</measure>
    <time_frame>From complete dilation until delivery</time_frame>
    <description>Duration (hrs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Labor Control</measure>
    <time_frame>Within 4 days postpartum</time_frame>
    <description>Score on Labor Agentry Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Obesity</condition>
  <condition>Labor Onset and Length Abnormalities</condition>
  <arm_group>
    <arm_group_label>Ambulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will be encouraged to ambulate with epidural in place.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Ambulation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This arm will undergo our current standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Ambulation</intervention_name>
    <description>Patients will be encouraged to ambulate for 20 minutes of every hour.</description>
    <arm_group_label>Ambulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Subjects capable of giving consent Singleton pregnancy Nulliparous (defined as no previous&#xD;
        pregnancy beyond 20 weeks 0 days) Gestational age greater than or equal to 37 weeks BMI &gt; =&#xD;
        35 at time of delivery admission Pain score &lt; 4 at time of consent Adult companion&#xD;
        available Anticipated vaginal delivery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Physical disability precluding ambulation Magnesium Administration Contraindications to&#xD;
        neuraxial analgesia Cerclage in current pregnancy Category III fetal heart tracing Fetal&#xD;
        Demise In Utero&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ann Dude</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ann Dude</last_name>
    <phone>773-702-3387</phone>
    <email>adude@bsd.uchicago.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sunitha Suresh</last_name>
    <email>sunitha.suresh@uchospitals.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annie Dude</last_name>
      <phone>773-702-3387</phone>
      <email>adude@bsd.uchicago.edu</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Scavone</last_name>
      <phone>(773) 834-8847</phone>
      <email>BScavone@dacc.uchicago.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ann Dude, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barbara Scavone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sunitha Suresh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Vallejo MC, Firestone LL, Mandell GL, Jaime F, Makishima S, Ramanathan S. Effect of epidural analgesia with ambulation on labor duration. Anesthesiology. 2001 Oct;95(4):857-61.</citation>
    <PMID>11605924</PMID>
  </reference>
  <reference>
    <citation>Collis RE, Harding SA, Morgan BM. Effect of maternal ambulation on labour with low-dose combined spinal-epidural analgesia. Anaesthesia. 1999 Jun;54(6):535-9.</citation>
    <PMID>10403865</PMID>
  </reference>
  <reference>
    <citation>Karraz MA. Ambulatory epidural anesthesia and the duration of labor. Int J Gynaecol Obstet. 2003 Feb;80(2):117-22.</citation>
    <PMID>12566183</PMID>
  </reference>
  <reference>
    <citation>Vahratian A, Zhang J, Troendle JF, Savitz DA, Siega-Riz AM. Maternal prepregnancy overweight and obesity and the pattern of labor progression in term nulliparous women. Obstet Gynecol. 2004 Nov;104(5 Pt 1):943-51.</citation>
    <PMID>15516383</PMID>
  </reference>
  <reference>
    <citation>Nuthalapaty FS, Rouse DJ, Owen J. The association of maternal weight with cesarean risk, labor duration, and cervical dilation rate during labor induction. Obstet Gynecol. 2004 Mar;103(3):452-6. Erratum in: Obstet Gynecol. 2004 May;103(5 Pt 1):1019.</citation>
    <PMID>14990405</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 6, 2020</study_first_submitted>
  <study_first_submitted_qc>August 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2020</study_first_posted>
  <last_update_submitted>September 14, 2020</last_update_submitted>
  <last_update_submitted_qc>September 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

